Publicidad

Publicidad

becas.universia.netBiblioteca.Net

Buscar recursos:

Buscador Google

Protection against cartilage and bone destruction by systemic interleukin-4 treatment in established murine type II collagen-induced arthritis

Descargar SCORM

Este recurso ha sido solicitado 1 veces (0 veces en los últimos 31 días).

Para poder solicitar este recurso debe identificarse como usuario de la biblioteca

 
Ver

Detalles del recurso

Marcadores Sociales
Protection against cartilage and bone destruction by systemic interleukin-4 treatment in established murine type II collagen-induced arthritis
Id. 17584480
Idioma inglés
Titulo Protection against cartilage and bone destruction by systemic interleukin-4 treatment in established murine type II collagen-induced arthritis
Autor(es) Joosten, Leo AB
Lubberts, Erik
Helsen, Monique MA
Saxne, Tore
Coenen-de Roo, Christina JJ
Heinegård, Dick
van den Berg, Wim B
Localización http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=17779
Versión 1.0
Estado Final
Descripción Destruction of cartilage and bone are hallmarks of human rheumatoid arthritis (RA), and controlling these erosive processes is the most challenging objective in the treatment of RA. Systemic interleukin-4 treatment of established murine collagen-induced arthritis suppressed disease activity and protected against cartilage and bone destruction. Reduced cartilage pathology was confirmed by both decreased serum cartilage oligomeric matrix protein (COMP) and histological examination. In addition, radiological analysis revealed that bone destruction was also partially prevented. Improved suppression of joint swelling was achieved when interleukin-4 treatment was combined with low-dose prednisolone treatment. Interestingly, synergistic reduction of both serum COMP and inflammatory parameters was noted when low-dose interleukin-4 was combined with prednisolone. Systemic treatment with interleukin-4 appeared to be a protective therapy for cartilage and bone in arthritis, and in combination with prednisolone at low dosages may offer an alternative therapy in RA.
Palabras clave Primary Research
Tipo de recurso Text
Tipo de Interactividad Expositivo
Nivel de Interactividad muy bajo
Audiencia Estudiante
Profesor
Autor
Estructura Atomic
Coste no
Copyright
Copyright © 1999 Current Science Ltd
Requerimientos técnicos Browser: Any
Fecha de contribución 05-feb-2008
Contacto

Valoración de los usuarios

No hay ninguna valoración para este recurso. Sea el primero en valorar este recurso.